GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.40
-0.10 (-0.57%)
May 8, 2026, 1:22 PM CST

TPE:3164 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
159.24103.73110.5155.6133.69169.95
Short-Term Investments
228.21261.62248.13272.71267.26251.78
Cash & Short-Term Investments
387.45365.36358.64328.3400.94421.73
Cash Growth
-0.25%1.87%9.24%-18.12%-4.93%-9.33%
Accounts Receivable
45.2846.1631.638.2350.3654.01
Other Receivables
1.170.741.731.791.41.05
Receivables
46.4646.8933.3340.0251.7655.06
Inventory
68.5470.3977.6788.1255.337.06
Prepaid Expenses
6.95.234.929.0713.4966.94
Other Current Assets
69.4467.4467.17---
Total Current Assets
578.77555.31541.73465.51521.5580.79
Property, Plant & Equipment
989.48976.291,0371,0601,1131,045
Long-Term Investments
--6.097.3226.5234.68
Other Intangible Assets
1.952.012.162.260.240.33
Long-Term Deferred Tax Assets
51.8451.8442.0439.722.7312.31
Other Long-Term Assets
80.9779.6479.8978.2911.5924.8
Total Assets
1,7031,6651,7091,6531,6961,698
Accounts Payable
9.058.146.37.8514.3711.39
Short-Term Debt
31.2323.520.48---
Current Portion of Long-Term Debt
-7.3112.242.24--
Current Portion of Leases
1.371.762.42.361.062.11
Current Income Taxes Payable
24.2522.7412.1918.9528.4433.82
Current Unearned Revenue
24.0722.0440.0533.9825.7625.33
Other Current Liabilities
119.0344.2946.4881.0191.1666.51
Total Current Liabilities
209129.78140.15146.39160.78139.17
Long-Term Debt
42.7644.949.2320.11--
Long-Term Leases
37.4532.8434.2633.633.4930.62
Long-Term Deferred Tax Liabilities
5.525.523.111.591.961.54
Other Long-Term Liabilities
2.322.322.322.372.372.32
Total Liabilities
297.05215.35229.07204.06198.59173.65
Common Stock
860.1860.1865.11865.11863.71863.71
Additional Paid-In Capital
334.57351.77353.74377.1375.69375.69
Retained Earnings
65.88113.34128.0289.97117.5154.87
Comprehensive Income & Other
25.415.664.9-15.88-5.58-17.83
Total Common Equity
1,2861,3311,3521,3161,3511,376
Minority Interest
119.99118.85127.9132.82145.89147.95
Shareholders' Equity
1,4061,4501,4801,4491,4971,524
Total Liabilities & Equity
1,7031,6651,7091,6531,6961,698
Total Debt
112.81110.31118.6158.3134.5532.73
Net Cash (Debt)
274.64255.05240.03270366.4389
Net Cash Growth
0.26%6.26%-11.10%-26.31%-5.81%-9.70%
Net Cash Per Share
3.192.952.773.124.234.48
Filing Date Shares Outstanding
86.0186.0186.5186.5186.3786.37
Total Common Shares Outstanding
86.0186.0186.5186.5186.3786.37
Working Capital
369.77425.53401.59319.12360.73441.62
Book Value Per Share
14.9515.4715.6315.2215.6515.94
Tangible Book Value
1,2841,3291,3501,3141,3511,376
Tangible Book Value Per Share
14.9315.4515.6015.1915.6415.93
Buildings
-926.21923.19886.14877.91168.74
Machinery
-492.34489.48481.71419.15234.11
Construction In Progress
--0.020.0375.24858.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.